ARROWHEAD PHARMACEUTICALS, INC. Tax Withholding Paid on Stock Awards
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Tax Withholding Paid on Stock Awards of $54.67 thousand for the 12-month period ending 2018-09-30, per its 10-K filed 2020-11-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2020-11-23
- ARROWHEAD PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2018-06-30 was $0.00.
- ARROWHEAD PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2017-09-30 was $21.70K.
- ARROWHEAD PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2017-06-30 was $0.00.
- ARROWHEAD PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2018 was $54.67K, a 87.54% decline from fiscal 2017.
- ARROWHEAD PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2017 was $438.84K, a 30.80% decline from fiscal 2016.
- ARROWHEAD PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2016 was $634.19K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-23 | $0.00 derived: sum of 2 quarters · filed 2020-11-23 | $54.67K 10-K · filed 2020-11-23 | |
| 2018-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-05 | $54.67K 10-Q · filed 2019-08-05 | ||
| 2018-03-31 | $54.67K 10-Q · filed 2019-05-08 | |||
| 2017-09-30 | $21.70K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-25 | $21.70K derived: sum of 2 quarters · filed 2019-11-25 | $21.70K derived: sum of 3 quarters · filed 2019-11-25 | $438.84K 10-K · filed 2019-11-25 |
| 2017-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-07 | $0.00 derived: sum of 2 quarters · filed 2018-08-07 | $417.14K 10-Q · filed 2018-08-07 | $417.14K derived: sum of 4 quarters · filed 2018-12-11 |
| 2017-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-08 | $417.14K 10-Q · filed 2018-05-08 | $417.14K derived: sum of 3 quarters · filed 2018-12-11 | $417.14K derived: sum of 4 quarters · filed 2018-12-11 |
| 2016-12-31 | $417.14K 10-Q · filed 2018-02-09 | $417.14K derived: sum of 2 quarters · filed 2018-12-11 | $417.14K derived: sum of 3 quarters · filed 2018-12-11 | $610.79K derived: sum of 4 quarters · filed 2018-12-11 |
| 2016-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | $0.00 derived: sum of 2 quarters · filed 2018-12-11 | $193.65K derived: sum of 3 quarters · filed 2018-12-11 | $634.19K 10-K · filed 2018-12-11 |
| 2016-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | $193.65K derived: sum of 2 quarters · filed 2017-08-03 | $634.19K 10-Q · filed 2017-08-03 | |
| 2016-03-31 | $193.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-03 | $634.19K 10-Q · filed 2017-05-03 | ||
| 2015-12-31 | $440.53K 10-Q · filed 2017-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |